Log in

NASDAQ:ECORelectroCore Stock Price, Forecast & News

$0.85
0.00 (0.00 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.82
Now: $0.85
$0.85
50-Day Range
$0.80
MA: $0.94
$1.29
52-Week Range
$0.32
Now: $0.85
$5.64
Volume2.56 million shs
Average Volume747,609 shs
Market Capitalization$32.41 million
P/E RatioN/A
Dividend YieldN/A
Beta1.04
electroCore, Inc., a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve (VNS) stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. The company is developing gammaCore, a prescription-only non-invasive VNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, which is a handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is headquartered in Basking Ridge, New Jersey.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.00 out of 5 stars


Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ECOR
CUSIPN/A
CIKN/A
Phone973-290-0097

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.39 million
Book Value$0.84 per share

Profitability

Net Income$-45,150,000.00
Net Margins-1,445.53%

Miscellaneous

Employees51
Market Cap$32.41 million
Next Earnings Date8/11/2020 (Estimated)
OptionableNot Optionable

Receive ECOR News and Ratings via Email

Sign-up to receive the latest news and ratings for ECOR and its competitors with MarketBeat's FREE daily newsletter.

electroCore (NASDAQ:ECOR) Frequently Asked Questions

How has electroCore's stock been impacted by COVID-19 (Coronavirus)?

electroCore's stock was trading at $0.5874 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ECOR stock has increased by 44.7% and is now trading at $0.85. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of electroCore?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for electroCore in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for electroCore.

When is electroCore's next earnings date?

electroCore is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for electroCore.

How were electroCore's earnings last quarter?

electroCore, Inc. (NASDAQ:ECOR) released its earnings results on Thursday, May, 14th. The company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.23) by $0.04. The firm had revenue of $0.73 million for the quarter, compared to the consensus estimate of $0.73 million. electroCore had a negative return on equity of 133.55% and a negative net margin of 1,445.53%. View electroCore's earnings history.

What guidance has electroCore issued on next quarter's earnings?

electroCore issued an update on its first quarter 2020 Pre-Market earnings guidance on Friday, April, 17th. The company provided EPS guidance of for the period. The company issued revenue guidance of $700K - 750K, compared to the consensus revenue estimate of $830K.

What price target have analysts set for ECOR?

6 Wall Street analysts have issued 12-month target prices for electroCore's shares. Their forecasts range from $1.50 to $10.00. On average, they anticipate electroCore's share price to reach $5.30 in the next year. This suggests a possible upside of 523.5% from the stock's current price. View analysts' price targets for electroCore.

Has electroCore been receiving favorable news coverage?

Media stories about ECOR stock have trended somewhat negative this week, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. electroCore earned a daily sentiment score of -1.2 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news about electroCore.

Are investors shorting electroCore?

electroCore saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 1,690,000 shares, an increase of 44.4% from the June 15th total of 1,170,000 shares. Based on an average trading volume of 2,010,000 shares, the days-to-cover ratio is presently 0.8 days. Approximately 6.0% of the company's shares are sold short. View electroCore's Current Options Chain.

Who are some of electroCore's key competitors?

What other stocks do shareholders of electroCore own?

Based on aggregate information from My MarketBeat watchlists, some companies that other electroCore investors own include Acasti Pharma (ACST), Vaxart (VXRT), Canopy Growth (CGC), Heat Biologics (HTBX), Outlook Therapeutics (OTLK), TherapeuticsMD (TXMD), FuelCell Energy (FCEL), Matinas BioPharma (MTNB), SCYNEXIS (SCYX) and T2 Biosystems (TTOO).

Who are electroCore's key executives?

electroCore's management team includes the following people:
  • Mr. Daniel S. Goldberger, CEO & Director (Age 61, Pay $187.5k)
  • Mr. Joseph P. Errico, Co-Founder, Principal Investor & Director (Age 51, Pay $776.28k)
  • Mr. Brian M. Posner, CFO & Corp. Sec. (Age 58, Pay $380.54k)
  • Dr. Peter S. Staats, Chief Medical Officer (Age 56, Pay $238.41k)
  • Mr. Michael Romaniw, VP of Operations, Systems & Logistics (Age 63)

When did electroCore IPO?

(ECOR) raised $64 million in an IPO on Friday, June 22nd 2018. The company issued 4,300,000 shares at $14.00-$16.00 per share. Evercore ISI and JMP Securities acted as the underwriters for the IPO and BTIG was co-manager.

What is electroCore's stock symbol?

electroCore trades on the NASDAQ under the ticker symbol "ECOR."

How do I buy shares of electroCore?

Shares of ECOR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is electroCore's stock price today?

One share of ECOR stock can currently be purchased for approximately $0.85.

How big of a company is electroCore?

electroCore has a market capitalization of $32.41 million and generates $2.39 million in revenue each year. The company earns $-45,150,000.00 in net income (profit) each year or ($1.54) on an earnings per share basis. electroCore employs 51 workers across the globe.

What is electroCore's official website?

The official website for electroCore is www.electrocore.com.

How can I contact electroCore?

electroCore's mailing address is 150 ALLEN ROAD SUITE 201, BASKING RIDGE NJ, 07920. The company can be reached via phone at 973-290-0097 or via email at [email protected]

This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.